NUCB1 and COVID-19: Nucleobinding 1 (NUCB1) is widely expressed in brain neurons and stabilizes amyloid protofibrils before they mature and become harmful in neurodegenerative diseases [104, 105]; however, its downregulation in our COVID-19 patients suggests decreased neurological protective mechanisms.